Haleon (HLN) Net Cash Flow Growth (1y) (2022 - 2023)

Haleon (HLN) Net Cash Flow Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn 112.26%
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn -44.11%
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 209.30%
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn -236.85%
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 13,485.29%
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -1,047.81%
9 Elanco Animal Health 12.60 Bn 12.18 Bn 785.00 Mn -1,020.00%
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn 383.33%

Historic Data

Download Data
DateValue
Dec 31, 2023 90.10%
Dec 31, 2022 -3,081.95%